Highlighted Researcher: Michael Davis

What is your professional background? 
I received my Bachelor’s from Rutgers in Biology and my PhD at Emory in Molecular and Systems Pharmacology. After my PhD, I performed postdoctoral research at Brigham and Women’s Hospital and MIT.

In what division do you work, and who is your mentor? 
I work in Biomedical Engineering, Cardiology, and Pediatrics, so I have lots!  Believe it or not, Dr. Kathy Griendling was on my thesis committee, and I still lean on her for advice. I am also mentored by Drs. Hanjoong Jo and Bob Taylor.

Briefly describe your research. Why is it important? 
Our laboratory researches novel approaches to cell therapy and drug delivery for adult and pediatric heart disease. Specifically, we use biomaterials to control the delivery of drugs and the fate of implanted cells. We also are now starting a clinical trial of progenitor cell therapy in patients with severe congenital heart defects (Hypoplastic Left Heart Syndrome). Recently, our laboratory has also started 3D printing for cardiac patches and valve tissue engineering.

What do you like most about Emory? 
I love the diversity in expertise and research areas. We collaborate with people in Chemistry, Winship, Radiology, Pediatrics, and more. I think being in a city with a top medical school, top engineering school, and top children’s hospital is unrivaled.

What is your favorite movie or TV show? 
Like most scientists, I love sci-fi movies but do not watch too much TV. I do enjoy Game of Thrones and Westworld.

What do you like to do in your spare time?
I have 2 children, so not much of that. I love to be outdoors, so I usually try to sneak in a lunchtime run. I love to travel as well.

Related Links

About the Author

Emory Department of Medicine
The Department of Medicine, part of Emory University's School of Medicine, promotes excellence in education, patient care, and clinical and basic research.

Be the first to comment on "Highlighted Researcher: Michael Davis"

Leave a comment

Your email address will not be published.




Share(s)